VA Rating Decision1 - 20040623 | |||||||
Code | Rating | Condition | Code | Rating Proximate |
|||
TDRL Placement |
TDRL Removal | TDRL2 Placement |
|||||
Asthma, Bronchial | 6602 | 60% | 10% | Asthma | 6602 | 10% | |
Recurrent Low Back Pain | Not Unfitting | Chronic Low Back Strain | 5237 | 10% | |||
Other x 3 | |||||||
RATING: 20% |
Pulmonary Function Tests (PFTs) | MEB ~ 17 mos. Pre-
Sep
(removal from TDRL)
|
VA ~ 11 mos. Pre-Sep (removal from TDRL) (20040309) |
VA ~ 7 weeks Pre-Sep (removal from TDRL) (20041230) |
TDRL
~
6 weeks
Pre-Sep |
FEV-1 (% of Predicted) | 60.6 | 70.8 | 76.5 | 66.5 |
FEV-1/FVC | 69.2% | 67.3% | 63.7% | 64.9% |
Meds | on oral Prednisone | on “inhalation treatment” | on Fluticasone (inhaled) | on Fluticasone (inhaled) |
CONDITION | VASRD CODE | RATING | |
TDRL | PERMANENT | ||
Asthma, bronchial | 6602 | 60% | 30% |
COMBINED | 60% | 30% |
AF | PDBR | CY2012 | PD2012 00957
The asthma conditionwas forwarded to the Physical Evaluation Board (PEB) IAW SECNAVINST 1850.4E.No other conditions were submitted by the MEB.The PEB found the severe persistent asthma unfitting, and rated it 10%.The CI made no appeals, and was medically separated. Using data from the treatment record, the Board determined that at the time of final separation from military service, the CI was being treated with daily inhalational corticosteroid anti-inflammatory medication. Considering all...
AF | PDBR | CY2014 | PD-2014-03148
Both the Air Force PEB and the VA coded the pulmonary condition 6602 (Asthma). The PEB rated it 10%, and the VA rated it 30%. Eight months later, she was using the anti-inflammatory corticosteroid Motametasone.Following a thorough review of the evidence in the treatment record, the Board concluded that it was more likely than not that the CI was using inhalational anti-inflammatory medication at the time of separation from service.
AF | PDBR | CY2012 | PD2012 01210
No other conditions were submitted by the MEB.The PEB adjudicated asthma with VCDand chronic pain left knee conditions as unfitting, rated 30% and 0% respectively,referencing the US Army Physical Disability Agency (USAPDA) pain policy. 660230%10%Asthma with Vocal Cord Dysfunction660230%20020606Chronic Pain, Left Knee In addition, the CI had a VCD that significantly responded to the beta-agonist inhalational medication, Albuterol for which the medication profile in evidence reflects dosing...
AF | PDBR | CY2011 | PD2011-00146
As noted above, the Army PEB found him unfit, and he was medically separated with a 10% disability rating. His lung exam was normal, with no wheezes noted. The Board does not have the authority to render fitness or rating recommendations for any conditions not considered by the DES.
AF | PDBR | CY2014 | PD-2014-01773
Post-Sep (200 70104 ) FEV-1 (% of Predicted) 94 % pre-drug, 94 % post-drug 73.5 % FEV-1/FVC 76 % pre-drug, 76 % post-drug 65.5 % Medications intermittent use of inhaled bronchodilator in termittent use of inhaled bronchodilator§ 4.97 Rating 1 0% 30%The Board directed attention to its rating recommendation based on the evidence above. The Board’s authority as defined in DoDI 6044.40, resides in evaluating the fairness of PEB fitness determinations and rating decisions for disability at the...
AF | PDBR | CY2012 | PD2012 01655
The CI was then medically separated. In reference to medications, the examiner simply stated “Now for asthma, she uses inhalers.” The VA PFT evidence cited an FEV1 of 103% predicted, and did not document an FVC. I have carefully reviewed the evidence of record and the recommendation of the Board.
AF | PDBR | CY2012 | PD2012-00469
The CI was re-evaluated almost 14 months later and the PEB recommended removal of the CI from the TDRL with a permanent disability rating of 10%. The PEB initially utilized VASRD code 6602, asthma, and rated it 30% based on daily inhaled medications with normal PFTs and placed the CI on TDRL. I direct that all the Department of the Army records of the individual concerned be corrected accordingly no later than 120 days from the date of this memorandum: individual was separated by reason of...
AF | PDBR | CY2013 | PD-2013-01602
DATE OF PLACEMENT ON TDRL: 20030706Date of Permanent SEPARATION: 20040720 BOARD FINDINGS : IAW DoDI 6040.44, provisions of DoD or Military Department regulations or guidelines relied upon by the PEB will not be considered by the Board to the extent they were inconsistent with the VASRD in effect at the time of the adjudication.The Board did not surmise from the record or PEB ruling in this case that any prerogatives outside the VASRD were exercised.In the matter of the asthma condition and...
AF | PDBR | CY2009 | PD2009-00263
The PEB’s DA Form 199 dated 20050413 indicated “Asthma, with normal spirometry, on intermittent inhalational bronchodilator therapy.” The PEB specified “Medication profile shows no controller medication between March – April 2004 and 15 February 2005.” The PEB permanent separation rating was 6602 at 10%; and the VASRD 10% criteria contains the phrasing “intermittent inhalational or oral bronchodilator therapy.” There is therefore no evidence that the provisions of DoDI 1332.39 were applied. ...
AF | PDBR | CY2013 | PD 2013 00179
It is limited to those conditions determined by the PEB to be unfitting for continued military service and those conditions identified but not determined to be unfitting by the PEB when specifically requested by the CI. The Board directs attention to its rating recommendationbased on the above evidence.Both the FPEB and the VA rated asthma condition,under code 6620, asthma, bronchial, IAW §4.97 but at different rating levels; the FPEB rated 10%citing intermittent use of medication; and the...